Given the evidence of Pyk2 and FAK expression in myeloid cells [49], PF-562271 may also impair the migratory capabilities of these cells, preventing significant infiltration into the tumor resection site and reducing the TIM component involved in tumor recurrence. The gene discussed is PTK2B; the disease is neoplasm.